Расширенный поиск

Анализ факторов прогноза у больных раком мочевого пузыря II стадии

Полный текст:

Об авторах

В. Ю. Василевич
ГУ НИИ ОМР им. Н.Н. Александрова

О. Г. Суконко
ГУ НИИ ОМР им. Н.Н. Александрова

Л. В. Мириленко
ГУ НИИ ОМР им. Н.Н. Александрова

А. И. Ролевич
ГУ НИИ ОМР им. Н.Н. Александрова

Список литературы

1. Поляков С.М., Левин Л.Ф., Шебеко Н.Г. Злокачественные новообразования в Беларуси, 1996–2005 гг. Под ред. А.А. Граковича, И.В. Залуцкого. Минск, БелЦМТ; 2006.

2. Матвеев Б.П., Фигурин К.М., Карякин О.Б. Рак мочевого пузыря. М., Вердана; 2001. с. 2–5.

3. Fujii Y., Kawakami S., Koga F. et al. Longterm outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 2003;92:559–62.

4. Zieger K., Wolf H., Olsen P.R., Hojgaard K. Long-term follow-up of non-invasive bladder tumours (stage Ta): recurrence and progression. BJU Int 2000;85:824–8.

5. Borhan A., Reeder J.E., O'Connell M.J. Grade progression and regression in recurrent urothelial cancer. J Urol 2003;169:2106–9.

6. Soloway M., Bruck D.S., Kim S.S. Expectant management of small recurrent, non-invasive papillary bladder tumours. J Urol 2003;170:438–41.

7. Sylvester R.J., Oosterlinck W., van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004;171:2186–90.

8. Sengupta S., Blute M.L. The management of superficial transitional cell carcinoma of the bladder. Urology 2006;67(3 Suppl1):48–54.

9. Gospodarowicz M. Radiotherapy and Organ Preservation in Bladder Cancer: Are We Ignoring the Evidence? J Clin Oncol 2002;14:3048–50.

10. Quek M.L., Stein J.P., Daneshmand S. et al. A critical analysis of perioperative mortality from radical cystectomy. J Urol 2006;175: 886–90.

11. Novotny V., Hakenberg O.W., Wiessner D. et al. Perioperative complication of radical cystectomy in a contemporary series. Eur Urol 2007; 51:397–402.

12. Michaelson M.D., Shipley W.U., Heney N.M. et al. Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder. Br J Cancer 2004; 90:578–81.

13. Rosenberg J.E., Carroll P.R., Small E.J. Update on chemotherapy for advanced bladder cancer. J Urol 2005;174:14–20.

14. Weizer A.Z., Joshi D., Daignault S. et al. Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. J Urol 2007;177:1287–93.

15. Sylvester R.J., van der Meijden A.P., Oosterlink W. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466–77.

16. Palou J. Patient risk profiles: prognostic factors of recurrence and progression. Eur Urol Suppl 2006;5:648-53.

17. Wazait H.D., Al-Bhueissi S.Z., Patel H.R. et al. Long-term surveillance of bladder tumours: current practice in the United Kingdom and Ireland. Eur Urol 2003;43:485-8.

18. Leibovitch L., Ben-Chaim J., Ramon J. et al. The significance of urethral obstruction in invasive transitional cell carcinoma of the urinary bladder. J Surg Oncol 1993;52:31.

19. Wallace A. Superficial bladder cancer. Comprehensive Urology. Ed. by R.M. Weiss, N.J.R. George, P.H. O’Reily; 2001. p. 363-73.

20. Tinzl M., Marberger M. Urinary Markers for Detecting Bladder Cancer. EAU Update Series 2003;1(2):64-70.

21. Satoh E., Miyao N., Tachiki H. Prediction of muscle invasion of bladder cancer by cystoscopy J. Urol 2002;41:178–81.

Для цитирования:

Василевич В.Ю., Суконко О.Г., Мириленко Л.В., Ролевич А.И. Анализ факторов прогноза у больных раком мочевого пузыря II стадии. Онкоурология. 2008;4(2):31-35.

For citation:

Vasilevich V.U., Sukonko O.G., Mirilenko L.V., Rolevich A.I. Prognostic factors analysis in patients with stage II bladder cancer. Cancer Urology. 2008;4(2):31-35. (In Russ.)

Просмотров: 61

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)